Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
Florida Cancer Specialists, Sarasota, Florida Columbia University Medical Center, New York, New York University Hospitals Cleveland Medical Center, Cleveland, Ohio Fred Hutchinson Cancer Center, Seattle, Washington United Kingdom
The Christie Nhs Foundation Trust, Manchester Royal Marsden Hospital (Sutton), Sutton